Abnormal liver tests and non-alcoholic fatty liver disease predict disease progression and outcome of patients with COVID-19
Simona Tripon(Inserm), Michel Doffoël(Mitochondrie, stress oxydant et protection musculaire), Hamid Merdji(Hôpital Civil, Strasbourg), Frédéric Chaffraix(Hôpitaux Universitaires de Strasbourg), Thibaut Fabacher(Université de Strasbourg), Pascal Bilbault(Université de Strasbourg), Pierrick Le Borgne(Centre National de la Recherche Scientifique), Sabrina Kepka(Université de Strasbourg), J. Müller(Hôpitaux Universitaires de Strasbourg), E. Schmitt(Universidade Estadual do Oeste do Paraná), Didier Mutter(Centre National de la Recherche Scientifique), Nicolas Lefèbvre(Hôpital Civil, Strasbourg), S. Lescuyer(Hôpitaux Universitaires de Strasbourg), Thomas F. Baumert(Inserm), Ferhat Meziani(Inserm), Emmanuel Andrès(Université de Strasbourg)
Clinics and Research in Hepatology and Gastroenterology
February 25, 2022
Cited by 15
Related Papers
Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey
|JACC Heart Failure|2017|271
Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81
|Hepatology|2007|244
RACK1 Controls IRES-Mediated Translation of Viruses
|Cell|2014|189
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication.
|Journal of Clinical Investigation|1996|180